Literature DB >> 24078628

Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and γ-secretase-dependent intramembranous cleavage.

Patrick Wunderlich1, Konstantin Glebov, Nadja Kemmerling, Nguyen T Tien, Harald Neumann, Jochen Walter.   

Abstract

Triggering receptor expressed on myeloid cells-2 (TREM2) and its signaling adaptor protein TYROBP/DAP12 play important roles in signal transduction in dendritic cells, osteoclasts, tissue macrophages, and microglia. Recently, TREM2 variants have been shown to be linked to late onset Alzheimer disease. Here, we demonstrate that TREM2 undergoes sequential proteolytic processing by ectodomain shedding and intramembrane proteolysis. The C-terminal fragment (CTF) of TREM2 generated by ectodomain shedding is cleaved by γ-secretase. Importantly, pharmacologic and genetic γ-secretase inhibition resulted in accumulation of TREM2 CTF at the plasma membrane that also interacts with the signaling adaptor protein DAP12. Thus, the accumulated TREM2 CTF thereby might limit the interaction of DAP12 with the functional full-length receptor, resulting in decreased DAP12 phosphorylation and impaired metabolism of phosphatidylinositol 4,5-bisphosphate. Together, these data demonstrate γ-secretase-mediated intramembranous proteolysis of TREM2 and functionally link two Alzheimer disease-associated proteins in one signaling pathway.

Entities:  

Keywords:  Alzheimer Disease; Intramembrane Proteolysis; Membrane; Presenilin; Protein Phosphorylation; Secretases; Signaling

Mesh:

Substances:

Year:  2013        PMID: 24078628      PMCID: PMC3829152          DOI: 10.1074/jbc.M113.517540

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

Review 1.  Intramembrane proteolysis by presenilins.

Authors:  H Steiner; C Haass
Journal:  Nat Rev Mol Cell Biol       Date:  2000-12       Impact factor: 94.444

2.  Requirements for presenilin-dependent cleavage of notch and other transmembrane proteins.

Authors:  G Struhl; A Adachi
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

3.  TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development.

Authors:  Marie-Claude Gingras; Hélène Lapillonne; Judith F Margolin
Journal:  Mol Immunol       Date:  2002-03       Impact factor: 4.407

4.  Syk regulation of phosphoinositide 3-kinase-dependent NK cell function.

Authors:  Kun Jiang; Bin Zhong; Danielle L Gilvary; Brian C Corliss; Eric Vivier; Elizabeth Hong-Geller; Sheng Wei; Julie Y Djeu
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

Review 5.  gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in?

Authors:  Sangram S Sisodia; Peter H St George-Hyslop
Journal:  Nat Rev Neurosci       Date:  2002-04       Impact factor: 34.870

6.  NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases.

Authors:  Simona Zompi; Jessica A Hamerman; Kouetsu Ogasawara; Edina Schweighoffer; Victor L J Tybulewicz; James P Di Santo; Lewis L Lanier; Francesco Colucci
Journal:  Nat Immunol       Date:  2003-05-11       Impact factor: 25.606

7.  Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.

Authors:  Jaewon Lee; Sic L Chan; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

8.  Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype.

Authors:  Juha Paloneva; Tuula Manninen; Grant Christman; Karine Hovanes; Jami Mandelin; Rolf Adolfsson; Marino Bianchin; Thomas Bird; Roxana Miranda; Andrea Salmaggi; Lisbeth Tranebjaerg; Yrjö Konttinen; Leena Peltonen
Journal:  Am J Hum Genet       Date:  2002-06-21       Impact factor: 11.025

9.  A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells.

Authors:  A Bouchon; C Hernández-Munain; M Cella; M Colonna
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

10.  Presenilin-1 affects trafficking and processing of betaAPP and is targeted in a complex with nicastrin to the plasma membrane.

Authors:  Christoph Kaether; Sven Lammich; Dieter Edbauer; Michaela Ertl; Jens Rietdorf; Anja Capell; Harald Steiner; Christian Haass
Journal:  J Cell Biol       Date:  2002-07-29       Impact factor: 10.539

View more
  115 in total

Review 1.  TREM2 variants: new keys to decipher Alzheimer disease pathogenesis.

Authors:  Marco Colonna; Yaming Wang
Journal:  Nat Rev Neurosci       Date:  2016-02-25       Impact factor: 34.870

Review 2.  Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?

Authors:  Yuetiva Deming; Zeran Li; Bruno A Benitez; Carlos Cruchaga
Journal:  Expert Opin Ther Targets       Date:  2018-06-20       Impact factor: 6.902

3.  Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy.

Authors:  Jerel Adam Fields; Brian Spencer; Mary Swinton; Emma Martine Qvale; María J Marquine; Arina Alexeeva; Sarah Gough; Benchawanna Soontornniyomkij; Elvira Valera; Eliezer Masliah; Cristian L Achim; Paula Desplats
Journal:  J Neurochem       Date:  2018-11-26       Impact factor: 5.372

4.  Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease.

Authors:  Michael Ewers; Nicolai Franzmeier; Marc Suárez-Calvet; Estrella Morenas-Rodriguez; Miguel Angel Araque Caballero; Gernot Kleinberger; Laura Piccio; Carlos Cruchaga; Yuetiva Deming; Martin Dichgans; John Q Trojanowski; Leslie M Shaw; Michael W Weiner; Christian Haass
Journal:  Sci Transl Med       Date:  2019-08-28       Impact factor: 17.956

5.  TREM2 sustains microglial expansion during aging and response to demyelination.

Authors:  Pietro Luigi Poliani; Yaming Wang; Elena Fontana; Michelle L Robinette; Yoshinori Yamanishi; Susan Gilfillan; Marco Colonna
Journal:  J Clin Invest       Date:  2015-04-20       Impact factor: 14.808

Review 6.  TREM2-Ligand Interactions in Health and Disease.

Authors:  Daniel L Kober; Tom J Brett
Journal:  J Mol Biol       Date:  2017-04-19       Impact factor: 5.469

7.  Trehalose Alters Subcellular Trafficking and the Metabolism of the Alzheimer-associated Amyloid Precursor Protein.

Authors:  Nguyen T Tien; Ilker Karaca; Irfan Y Tamboli; Jochen Walter
Journal:  J Biol Chem       Date:  2016-03-08       Impact factor: 5.157

Review 8.  Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.

Authors:  Alison E Mungenast; Sandra Siegert; Li-Huei Tsai
Journal:  Mol Cell Neurosci       Date:  2015-12-04       Impact factor: 4.314

Review 9.  Alzheimer's disease genetics: from the bench to the clinic.

Authors:  Celeste M Karch; Carlos Cruchaga; Alison M Goate
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

10.  TYROBP genetic variants in early-onset Alzheimer's disease.

Authors:  Cyril Pottier; Thomas A Ravenscroft; Patricia H Brown; NiCole A Finch; Matt Baker; Meeia Parsons; Yan W Asmann; Yingxue Ren; Elizabeth Christopher; Denise Levitch; Marka van Blitterswijk; Carlos Cruchaga; Dominique Campion; Gaël Nicolas; Anne-Claire Richard; Rita Guerreiro; Jose T Bras; Stephan Zuchner; Michael A Gonzalez; Guojun Bu; Steven Younkin; David S Knopman; Keith A Josephs; Joseph E Parisi; Ronald C Petersen; Nilüfer Ertekin-Taner; Neill R Graff-Radford; Bradley F Boeve; Dennis W Dickson; Rosa Rademakers
Journal:  Neurobiol Aging       Date:  2016-08-08       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.